Medication or HIFU for Fibroids: What Does Each Approach Aim to Do?

Medicines and HIFU are not interchangeable treatments for uterine fibroids. Medicines may help manage bleeding or pain, while high-intensity focused ultrasound aims to ablate selected fibroid tissue using focused energy. The useful question is not which option is universally better, but which problem needs treatment, what each option can realistically achieve and what follow-up it requires. A recommendation needs an individual clinical assessment. [1,2]

Start with the goal, not the treatment name

Heavy bleeding, period pain and pressure symptoms are different treatment goals. A smaller amount of bleeding can be a meaningful benefit even if a fibroid remains present. Conversely, an imaging change after a procedure is not by itself proof that every symptom has improved.

NICE recommends considering a person's preferences, other health conditions, symptoms, and the size, number and location of fibroids when discussing treatment for heavy menstrual bleeding. Its guidance is not a rule that everyone with a fibroid needs a procedure. [1] Ask your clinician to name the main symptom being treated and how you will judge whether treatment is helping.

What medicines may aim to do

For heavy menstrual bleeding, options discussed in NICE guidance include non-hormonal medicines such as tranexamic acid and non-steroidal anti-inflammatory drugs (NSAIDs), and hormonal options such as an LNG-IUS, combined hormonal contraception or cyclical oral progestogens. These are not equivalent choices and are not suitable for everyone. [1]

For example, NICE's recommendation to consider an LNG-IUS first applies to particular circumstances, including fibroids under 3 cm that do not distort the uterine cavity. It should not be read as a recommendation for every fibroid pattern. For larger fibroids, specialist discussion considers symptoms and fibroid characteristics as well as the available treatments. [1]

Current UK guidance also links to specific GnRH-antagonist treatment appraisals for some people with moderate-to-severe fibroid symptoms. A drug name in a UK guideline does not establish that it is approved, available, appropriate or prescribed at a clinic in Korea. This article is not a medication menu for BARUN. [1]

Before starting a medicine, ask:

• Is the main goal less bleeding, less pain or another effect?
• Which health conditions, other medicines or pregnancy plans could make it unsuitable?
• What side effects should prompt advice, and when should benefit be reviewed?
• Is it intended for ongoing symptom management or a particular stage of care?
• What is the plan if it does not help or cannot be continued?

Duration and monitoring depend on the specific medicine and the person. Do not start, stop or change a prescription on the basis of a comparison article.

Medicines can have a role while a longer-term plan is being assessed

Medication does not automatically mean that treatment has failed or that a procedure has only been delayed. NICE recommends tranexamic acid and/or NSAIDs, when appropriate, while investigations and definitive treatment are being organised for heavy bleeding with larger fibroids. It also advises continuing them for as long as they are beneficial. [1]

At the same time, NICE cautions that medication for heavy menstrual bleeding may be less effective when fibroids are substantially larger than 3 cm. This is not a claim that all drugs stop working at a single measurement, or that size alone selects HIFU. [1] Persistent symptoms, side effects or changing priorities are reasons to review the plan rather than increase or combine treatments yourself.

What ultrasound-guided HIFU aims to do

Ultrasound-guided HIFU uses imaging to guide focused ultrasound energy to a planned target, producing heat to ablate tissue. It is a local procedure, not a prescription medicine and not surgical removal of a fibroid. A clinician must assess whether the relevant target and a safe treatment route can be identified. [2,3]

BARUN uses ultrasound-guided HIFU. Evidence or patient information about MRI-guided focused ultrasound should not automatically be treated as evidence for the same device, monitoring method or expected result.

NICE's ultrasound-guided HIFU guidance describes limited-quality evidence on efficacy and recognised complications, including skin burns. In the UK, it recommends special arrangements for clinical governance, consent, and audit or research, with multidisciplinary selection, specialised centres and specifically trained clinicians. This is a statement of that guidance, not a description or certification of BARUN's internal processes. [2]

Consent should explain that symptoms may not fully resolve, may return and may require further procedures. Effects on fertility and future pregnancy remain uncertain. HIFU should not be presented as a permanent cure, a guaranteed way to avoid surgery or a proven fertility advantage over medicines or other treatments. [2]

Compare a care plan, not just a pill and a procedure

A useful comparison covers what happens next as well as the initial treatment. Ask how symptoms will be reviewed, what follow-up is needed, and which findings would change the plan. If medication is being considered before or after HIFU, ask why it is needed in your case. There is no universal medication schedule in this article for preparing for HIFU or managing symptoms afterwards.

Other choices can include observation when appropriate, uterine artery embolisation, myomectomy, hysterectomy or other procedures, depending on the diagnosis, symptoms and goals. Some cavity-related fibroids may prompt discussion of hysteroscopic removal. Preserving the uterus is not the same as proving that a treatment improves the chance of pregnancy. [1,2]

Bring a list of current prescriptions, supplements and previous treatments, along with available scan reports and your main questions. At BARUN, ask which options can be assessed or provided locally and which would require another service. This article does not confirm individual drug availability, pricing, treatment eligibility or a travel timetable.

Frequently asked questions

If medicine controls my bleeding, do I still need HIFU?

Not automatically. The remaining symptoms, clinical findings and your priorities matter. Ask whether the current benefit is sufficient and what review is appropriate. The presence of a fibroid alone does not decide the next treatment. [1]

Does trying medication first make HIFU less suitable later?

A history of medication use is not enough to answer that question. Tell the clinician what you took, why, whether it helped and any adverse effects. A later procedure still requires its own assessment; this article cannot predict suitability or prescribe a required sequence.

Will HIFU mean I can stop all fibroid medicines?

That cannot be promised. Symptoms may persist or return, and further treatment can be needed. Any change to prescribed treatment should be agreed with the clinician responsible for your care. [2]

Can I use a UK or US drug recommendation when arranging care in Korea?

Use it as a discussion point, not as confirmation of local access or a personal prescription. Licensing, formulations and clinical pathways can differ. Ask about the specific product and your own contraindications before making treatment or travel plans.

Related reading

• What a HIFU treatment-plan review can and cannot tell you
• How doctors assess HIFU candidacy
• Heavy periods and iron deficiency: which tests might you need?

Sources and evidence limits

1. NICE NG88: Heavy menstrual bleeding, recommendations, especially 1.5.1–1.5.15. Current guideline checked 9 November 2026; guideline last reviewed 7 July 2026. UK guidance, not a Korean prescribing protocol.
2. NICE HTG523: Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids, recommendations. Published 24 July 2019; checked 9 November 2026. The January 2026 move from IPG657 to HTG523 did not change the clinical recommendations.
3. NICE HTG523: The condition, current treatments and procedure. Ultrasound-guided procedure description; checked 9 November 2026.

These sources explain treatment roles and limitations. They do not establish a head-to-head advantage for HIFU over medication or predict an individual result.

Prepared with AI assistance by Aside AI, 9 November 2026. General health education only, not a diagnosis or an individual treatment recommendation.